2703 related articles for article (PubMed ID: 16706809)
21. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis.
Ando T; Kusugami K; Ohsuga M; Shinoda M; Sakakibara M; Saito H; Fukatsu A; Ichiyama S; Ohta M
Am J Gastroenterol; 1996 Jun; 91(6):1150-6. PubMed ID: 8651162
[TBL] [Abstract][Full Text] [Related]
23. Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition.
Tahara T; Shibata T; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Nakagawa Y; Nagasaka M; Iwata M; Nakamura M; Hirata I; Arisawa T
Hepatogastroenterology; 2012; 59(120):2416-20. PubMed ID: 23169178
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Koskenpato J; Färkkilä M; Sipponen P
Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
[TBL] [Abstract][Full Text] [Related]
25. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-13 mucosal production in Helicobacter pylori-related gastric diseases.
Marotti B; Rocco A; De Colibus P; Compare D; de Nucci G; Staibano S; Tatangelo F; Romano M; Nardone G
Dig Liver Dis; 2008 Apr; 40(4):240-7. PubMed ID: 18243827
[TBL] [Abstract][Full Text] [Related]
27. [Diagnostic value of different methods applied for detecting Helicobacter pylori infection in gastric mucosa].
Korzonek M
Ann Acad Med Stetin; 1997; 43():143-59. PubMed ID: 9471913
[TBL] [Abstract][Full Text] [Related]
28. Essential role of Peyer's patches in the development of Helicobacter-induced gastritis.
Kiriya K; Watanabe N; Nishio A; Okazaki K; Kido M; Saga K; Tanaka J; Akamatsu T; Ohashi S; Asada M; Fukui T; Chiba T
Int Immunol; 2007 Apr; 19(4):435-46. PubMed ID: 17314082
[TBL] [Abstract][Full Text] [Related]
29. FOXP3-expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated to CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients.
Kindlund B; Sjöling A; Hansson M; Edebo A; Hansson LE; Sjövall H; Svennerholm AM; Lundin BS
Helicobacter; 2009 Jun; 14(3):192-201. PubMed ID: 19702849
[TBL] [Abstract][Full Text] [Related]
30. Il-2 receptor expression on gastric mucosa T lymphocytes is enhanced in duodenal ulcer patients compared with non-ulcer dyspeptic patients.
Ihan A; Tepez B; Kavcic I; Gubina M
Hepatogastroenterology; 1996; 43(12):1665-70. PubMed ID: 8975986
[TBL] [Abstract][Full Text] [Related]
31. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
32. IL-1beta and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes.
Chang YW; Oh HC; Jang JY; Hwangbo Y; Lee JW; Lee HJ; Joo KR; Dong SH; Kim SS; Kim HJ; Kim BH; Chang R
Scand J Gastroenterol; 2008; 43(10):1184-93. PubMed ID: 18609140
[TBL] [Abstract][Full Text] [Related]
33. Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX-2 expression in patients with chronic gastritis and gastric cancer.
Bartchewsky W; Martini MR; Masiero M; Squassoni AC; Alvarez MC; Ladeira MS; Salvatore D; Trevisan M; Pedrazzoli J; Ribeiro ML
Scand J Gastroenterol; 2009; 44(2):153-61. PubMed ID: 18985541
[TBL] [Abstract][Full Text] [Related]
34. Protease-activated receptor-2 (PAR2) in human gastric mucosa as mediator of proinflammatory effects in Helicobacter pylori infection.
Kandulski A; Kuester D; Mönkemüller K; Fry L; Malfertheiner P; Wex T
Helicobacter; 2011 Dec; 16(6):452-8. PubMed ID: 22059396
[TBL] [Abstract][Full Text] [Related]
35. Natural killer cell receptor T-lymphocytes in normal and Helicobacter pylori-infected human gastric mucosa.
O'Keeffe J; Gately CM; O'Donoghue Y; Zulquernain SA; Stevens FM; Moran AP
Helicobacter; 2008 Dec; 13(6):500-5. PubMed ID: 19166415
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori infection is associated with increased expression of macrophage migratory inhibitory factor--by epithelial cells, T cells, and macrophages--in gastric mucosa.
Xia HH; Lam SK; Huang XR; Wong WM; Leung SY; Yuen ST; Lan HY; Wong BC
J Infect Dis; 2004 Jul; 190(2):293-302. PubMed ID: 15216464
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
38. Influence of H. pylori infection and eradication on p53, c-erbB-2 and Ki-67 in gastric mucosa.
Brajsa K; Ferencic Z; Katicic M; Radosevic S; Presecki V; Spaventi R; Dominis M
Hepatogastroenterology; 2006; 53(72):968-72. PubMed ID: 17153465
[TBL] [Abstract][Full Text] [Related]
39. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection.
Hwang IR; Kodama T; Kikuchi S; Sakai K; Peterson LE; Graham DY; Yamaoka Y
Gastroenterology; 2002 Dec; 123(6):1793-803. PubMed ID: 12454835
[TBL] [Abstract][Full Text] [Related]
40. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor.
Coyle WJ; Sedlack RE; Nemec R; Peterson R; Duntemann T; Murphy M; Lawson JM
Am J Gastroenterol; 1999 Oct; 94(10):2885-9. PubMed ID: 10520838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
